Tell me pathophysiology of pneumonia as per latest harrison

Reading File

Finding Sources

Reading File

I have all the information I need from Harrison's 22nd Edition (2025) Chapter 131. The pathophysiology section was fully captured in the first large read. Let me now compile the comprehensive answer.

Here is the pathophysiology of pneumonia as described in Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter 131 (Mandell & Niederman):

Pathophysiology of Pneumonia - Harrison's 22nd Edition

1. Revised Conceptual Framework - The Lung Microbiome Paradigm

Older teaching held that the lungs are sterile, and pneumonia results from invasion of a sterile space by a pathogen. Harrison's 22E explicitly revises this:

"Pneumonia therefore does not appear to be the result of the invasion of a sterile space by a particular microorganism but is more likely an emergent phenomenon dependent upon a number of mechanisms, including self-accelerating positive feedback loops."

The lungs harbor a complex and diverse lung microbiota. Pneumonia is now understood as a disruption of dynamic homeostasis within this microbial community rather than simple pathogen invasion.

2. Routes of Microbial Entry

Mechanical host defenses include:

Nasal hairs and turbinates
Branching architecture of the tracheobronchial tree
Mucociliary clearance
Gag and cough reflexes

These are insufficient to completely prevent bacterial access to the lower airways. Microorganisms reach the lower respiratory tract via:

Microaspiration of oropharyngeal organisms (most common)
Inhalation of aerosols
Direct mucosal dispersion
Macroaspiration (in aspiration pneumonia, accounts for ~5-15% of CAP)
Hematogenous spread (less common, e.g., right-sided endocarditis, septic emboli)

3. The Lung Microbiota Model

The composition of the lung microbiota is governed by three factors:

Rate of microbial entry into the lungs
Rate of microbial elimination
Regional growth conditions (pH, oxygen tension, temperature)

When this balance is disturbed, conditions favor pathogen proliferation, triggering a cascade toward clinical pneumonia.

4. Proposed Mechanistic Model (Positive Feedback Loop)

Harrison's 22E describes a specific pathophysiologic cascade:

An inflammatory event causes epithelial and/or endothelial injury
This triggers release of cytokines, chemokines, and catecholamines
These mediators create favorable growth conditions for certain organisms (e.g., upregulation of receptors for bacterial adhesion)
Bacterial proliferation intensifies inflammation - creating a self-accelerating positive feedback loop
Loss of alveolar architecture and alveolar flooding follows

This explains why certain organisms with seemingly low pathogenicity can cause severe pneumonia given the right inflammatory milieu.

5. Innate and Adaptive Immunity in Pneumonia

The host's innate immunity is the first line:

Alveolar macrophages are the dominant early responders; they engulf and kill organisms and secrete cytokines/chemokines that recruit neutrophils
When the bacterial load overwhelms macrophage capacity, a robust inflammatory response is mounted
Neutrophils flood the alveoli, forming the exudate (the pathological basis of consolidation)

Adaptive immunity (T-cell and B-cell mediated) is slower but important for resolution and clearance of encapsulated organisms (e.g., Streptococcus pneumoniae).

6. Alveolar Flooding and Gas Exchange Impairment

As infection progresses:

Protein-rich exudate, neutrophils, fibrin, and red blood cells fill the alveoli
This creates the four classic pathologic stages (more applicable to pneumococcal lobar pneumonia):
1. Congestion - vascular engorgement, few bacteria in alveoli
2. Red hepatization - alveoli packed with RBCs, neutrophils, fibrin
3. Grey hepatization - RBC lysis, fibrin network remains, macrophages appear
4. Resolution - enzymatic digestion of exudate, restoration of architecture
Alveolar flooding impairs ventilation-perfusion (V/Q) matching
Affected lung units continue to be perfused but not ventilated → intrapulmonary shunt
Result: hypoxemia, the cardinal physiologic derangement

7. Systemic Manifestations

The inflammatory cytokine cascade (TNF-α, IL-1, IL-6, IL-8) mediates systemic features:

Fever (prostaglandin E2 at the hypothalamus)
Leukocytosis (IL-6, G-CSF effect on bone marrow)
Malaise, anorexia (systemic cytokine effects)
Pleuritic chest pain (when pleura is involved by inflammation)

In severe CAP, the cascade can progress to:

Sepsis (uncontrolled systemic inflammatory response)
ARDS (diffuse alveolar damage, massive cytokine-driven lung injury)
Multi-organ dysfunction

8. Pathogen-Specific Notes (Harrison's 22E)

Streptococcus pneumoniae: Most common CAP pathogen; capsule resists phagocytosis; rapid cascade once defenses overcome (highlighted in Harrison's with data showing antibiotics often cannot abort the cascade once initiated)
Atypicals (Mycoplasma, Chlamydia, Legionella): Intracellular or parasite-like biology; evade phagocytosis differently; tend to cause interstitial patterns
Staphylococcus aureus / MRSA: Produces toxins (including Panton-Valentine leukocidin in community strains) causing necrotizing pneumonia with rapid tissue destruction
Gram-negatives (Klebsiella, Pseudomonas): Common in HAP/VAP; endotoxin-driven massive inflammatory response; often in aspiration-prone or immunocompromised patients

9. HAP and VAP - Additional Pathophysiologic Considerations

In hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP):

Altered oropharyngeal flora (colonization with gram-negatives and MRSA)
Impaired mucociliary clearance (endotracheal intubation bypasses upper airway defenses)
Microaspiration around endotracheal tube cuff is the dominant mechanism in VAP
Biofilm formation on endotracheal tubes serves as a persistent bacterial reservoir

Source: Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter 131 - Pneumonia (Lionel A. Mandell, Michael S. Niederman), pp. 1066 onwards.

This is a shared conversation. Sign in to Orris to start your own chat.